Jon is very excited about NNZ-2591 which is the potential treatment for Angelman Syndrome, and he thinks it could be bigger than Daybue. Imo this would be a massive company maker on top of what it is at the mo! Bring on the NNZ-2591 trials!! I would not be worrying about the share price as it has been bought down by the bs culper report as we know where Neuren is headed which is blue skies!!!
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$12.96 |
Change
-0.140(1.07%) |
Mkt cap ! $1.612B | |||
| Open | High | Low | Value | Volume |
| $13.20 | $13.36 | $12.82 | $4.627M | 354.8K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 7585 | $12.96 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $13.03 | 3344 | 2 |
View Market Depth
| Last trade - 16.10pm 16/06/2025 (20 minute delay) ? |
| NEU (ASX) Chart |